This item requires a subscription to Diabetes Care.
Full Text (PDF)
Original Research - Emerging Treatments & Technologies:
Michael A. Nauck,
Robert E. Ratner,
Christoph Kapitza,
Rachele Berria,
Mark Boldrin,
and Raffaella Balena
Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic
Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: A double-blind placebo-controlled study Diabetes Care July 2009 32:1237-1243; published ahead of print April 14, 2009, doi:10.2337/dc08-1961